These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4659148)

  • 1. The restoration of the reactivity of higher autonomic centers by pyrithioxin administration in cerebral infarct patients.
    Stoica E; Stefanescu E; Gheorghiu M
    Eur Neurol; 1972; 7(6):348-63. PubMed ID: 4659148
    [No Abstract]   [Full Text] [Related]  

  • 2. Facilitation through hyperventilation of therapeutic effect of pyrithioxin in cerebral infarct patients.
    Stoica E; Enulescu O; Gheorghiu M
    Eur Neurol; 1975; 13(4):285-303. PubMed ID: 1097256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations in urinary excretion of vanilmandelic acid under hypoglycaemia in cerebrovascular accidents.
    Stoica E; Bălăceanu C; Stefănescu E
    Brain; 1970; 93(3):641-52. PubMed ID: 5507018
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of centrophenoxine and ephedrine on the hyporeactivity of the autonomic centres in patients with cerebral infarction.
    Stoica E; Enulescu O; Gheorghiu M
    Rev Roum Neurol Psychiatr; 1974; 11(1):33-45. PubMed ID: 4151400
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of cerebral vascular diseases due to softening].
    Tomaselli R; Elia C
    Omnia Med Ther; 1968; 46(3):657-70. PubMed ID: 4989937
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences on the treatment of cerebral insufficiency and peripheral circulation disorders with the test preparation EP 50-100].
    Bock KJ
    Med Welt; 1972 Feb; 23(8):273-5. PubMed ID: 5012543
    [No Abstract]   [Full Text] [Related]  

  • 7. Unresponsiveness to hypoglycemia of centers controlling epinephrine release in cerebral infarct patients.
    Stoica E; Enulescu O
    Eur Neurol; 1979; 18(6):395-8. PubMed ID: 397898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of ACTH, metopirone and dexamethasone on urinary excretion of 3-methoxy-4-hydroxymandelic acid (VMA) in patients following cerebral stroke].
    Kawiak W; Stelmasiak Z
    Neurol Neurochir Pol; 1971; 5(5):637-42. PubMed ID: 4334446
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chronic cerebrovascular diseases associated with metabolic syndrome: new treatment approaches].
    Tanashian MM; Lagoda OV; Antonova KV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(11):21-6. PubMed ID: 23257741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of papaverine on systemic and cerebral hemodynamics in atherosclerosis complicated by chronic cerebral circulatory insufficiency].
    Komorovskaia IaM; Nechaĭ EE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1308-12. PubMed ID: 6506974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of papaverine on cerebrospinal fluid and blood acid-base balance in patients with vascular diseases of the brain].
    Gabrielian ES; Zograbian SG; Amroian EA; Dadivanian IuP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(8):1168-72. PubMed ID: 973520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of the effectiveness of papaverine in the long-term therapy of cerebral ischemia].
    Dam M; Battistin L
    Clin Ter; 1981 Dec; 99(5):483-8. PubMed ID: 7333069
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cerebrovascular disorders. Conservative therapy using Kollateral forte].
    Feine-Haake G
    ZFA (Stuttgart); 1980 Mar; 56(8):575-8. PubMed ID: 7415502
    [No Abstract]   [Full Text] [Related]  

  • 14. Testing for cerebrovascular reactivity. A method for estimation of the efficiency of cerebral vasodilating therapy in cerebrovascular disease.
    Sterman-Marinchescu C; Georgescu G; Teodorini E
    Rev Roum Neurol; 1973; 10(4):325-40. PubMed ID: 4588383
    [No Abstract]   [Full Text] [Related]  

  • 15. [Papaverine in high doses in the treatment of cerebral circulatory insufficiency in senescence and senility. (Clinico-statistical study of 474 cases)].
    Ferliga G
    G Gerontol; 1966 Apr; 14(4):345-63. PubMed ID: 5911913
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of cerebral circulatory insufficiency. Double-blind study of the efficacy of a quinine-papaverine combination].
    Klemm J
    Fortschr Med; 1984 Oct; 102(39):1000-2. PubMed ID: 6389288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between the reactivity of cerebral vessels to hypocapnia and the response of the glycostatic mechanism in cerebral infarct patients.
    Stoica E; Sterman-Marinchescu C
    Rev Roum Neurol; 1971; 8(5):391-400. PubMed ID: 5140611
    [No Abstract]   [Full Text] [Related]  

  • 18. Papaverine for cerebral and other vascular disorders.
    Med Lett Drugs Ther; 1970 Mar; 12(6):26-7. PubMed ID: 5510015
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment and prevention of cerebral arterial disorders in aged and of their consequences. Rheoencephalographic examinations].
    Albot G; Goutmer B; Treps J
    Therapeutique; 1971; 47(6):579-84. PubMed ID: 5571174
    [No Abstract]   [Full Text] [Related]  

  • 20. Improvement in brain oxygenation and clinical improvement in patients with strokes treated with papaverine hydrochloride.
    Meyer JS; Gotoh F; Gilroy J; Nara N
    JAMA; 1965 Nov; 194(9):957-61. PubMed ID: 5897963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.